Trial reportMovement disorders clinical practice2025
Randomized Observer-Blind Study on the Effects of Neuromuscolar Taping in Parkinson's Disease Patients.
Trial report in Movement disorders clinical practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAbnormal posture occurs in about 30% of Parkinson's disease (PD) patients. The neuromuscular taping (NMT) is a new treatment that induces micromovements that stimulate skin receptors. Application of NMT with a decompression and eccentric technique expands the interstitial spaces and therefore improves circulation and absorption of liquids by reducing the pressure under the skin favoring the muscular relaxation.
objectivesWe conducted a 4-week, randomized, observer-blind, trial of NMT on pharmacologically treated PD patients with postural abnormality according to the item 3.13 of Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS).
methodsThe primary endpoint of the study was the change in kinetic evaluation using movement analysis technique. Main secondary endpoint was change in scale UPDRS part III score from baseline to week 4, comparing NMT+Pharmacological therapy (NMT+PT) or only Pharmacological therapy (PT). 46 PD patients were enrolled and randomly assigned to two groups. Both groups remained on stable pharmacological treatment throughout the entire duration of the study. The NMT-PT group received 8 sessions of specific decompression with neuromuscular taping.
resultsAt the end of the study, the kinematic data showed statistically significant change in α1 (the parameter related to the sagittal trunk inclination), close to 12% of improvement in the NMT-PT group.
conclusionsResults showed a significant improvement in some kinematic parameters along with an improvement in motor and nonmotor symptoms in NMT + PT group compared to PT. NMT can represent a valid therapeutic option in combination with neurorehabilitation to treat abnormal posture in PD patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.